IP Library Granted Patent US 11,320,350
Granted Patent B2
US 11,320,350 · App. 16/339,655 · Granted May 3, 2022

Method for agglutinating erythrocytes, method for separating erythrocytes, and hemagglutination reagent

Inventors: Shino Muramatsu (Gosen, JP); Daisuke Kato (Gosen, JP); Tomohiro Hattori (Gosen, JP)
Assignee: DENKA COMPANY LIMITED
G01N1/4044G01N33/48
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,320,350
App. No.
16/339,655
Granted
May 3, 2022
Kind
B2
Abstract

Methods of agglutinating and separating erythrocytes, by which erythrocytes can be instantaneously agglutinated into a sufficient size in a blood sample and completely separated from the blood sample; and a hemagglutination reagent are provided. The method of agglutinating erythrocytes according to the present invention includes adding a solution containing a cholic acid-based surfactant and an acid to a blood sample. The method of separating erythrocytes according to the present invention includes separating the erythrocytes agglutinated by the above-described method of the present invention. The hemagglutination reagent according to the present invention contains a cholic acid-based surfactant and an acid.

Claims (9)

1. A method of agglutinating erythrocytes, the method comprising adding a solution containing a cholic acid-based surfactant and an acid to a blood sample, wherein said solution has a pH of from 2.5 to 4.0 and wherein the cholic acid-based surfactant is sodium taurodeoxycholate hydrate.

2. A method of separating erythrocytes from a blood sample, the method comprising separating erythrocytes agglutinated by the method according to claim 1 .

3. A hemagglutination reagent, which contains a cholic acid-based surfactant and an acid, wherein said reagent has a pH of from 2.5 to 4.0 and wherein the cholic acid-based surfactant is sodium taurodeoxycholate hydrate.

4. Use of the reagent according to claim 3 , as a reagent for agglutinating erythrocytes.

5. The method of claim 1 , wherein the method does not employ centrifugation.

6. The method of claim 1 , wherein said sample consists of whole blood, optionally diluted with a diluent.

7. The method of claim 6 , wherein said diluent consists of a physiological saline solution.

8. The method of claim 1 , wherein the concentration of the sodium taurodeoxycholate hydrate in the solution is from 0.1 to 6.0% by weight.

9. The method of claim 3 , wherein the concentration of the sodium taurodeoxycholate hydrate in the reagent is from 0.1 to 6.0% by weight.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBERS 10007286 AND 10415007 PREVIOUSLY RECORDED AT REEL: 054513 FRAME: 0142. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Dec 14, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 055437/0045 →
MERGER Recorded Nov 24, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 054513/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2019
From: MURAMATSU, SHINO; KATO, DAISUKE; HATTORI, TOMOHIRO
To: DENKA SEIKEN CO., LTD.
Reel/Frame 049596/0530 →
Priority Claims (1)
JP JP2016-196963 · Oct 5, 2016 · national
Continuity (1)
Related Publication 20190226952A1 · Jul 25, 2019